研究者業績

石川 浩章

イシカワヒロアキ  (ishikawa hiroaki)

基本情報

所属
藤田医科大学 医療科学部 医療検査学科 基礎病態解析学 准教授
学位
博士(医学)

J-GLOBAL ID
200901065684943874
researchmap会員ID
1000289480

研究キーワード

 2

委員歴

 1

受賞

 1

論文

 27
  • Hiroya Yamada, Eiji Munetsuna, Mirai Yamazaki, Genki Mizuno, Nao Sadamoto, Yoshitaka Ando, Ryosuke Fujii, Kazuya Shiogama, Hiroaki Ishikawa, Koji Suzuki, Yohei Shimono, Koji Ohashi, Shuji Hashimoto
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology 33(10) 11431-11442 2019年10月  査読有り
    Fructose consumption is rising globally, but maternal high fructose intake might adversely affect offspring. Our previous report demonstrated that excess maternal fructose intake impairs hippocampal function in offspring, indicating that the hippocampi of offspring are highly sensitive to maternal fructose. Here, we examined the effect of maternal high fructose on mitochondrial physiology and uncoupling protein (UCP) expression. Rat dams received a 20% fructose solution during gestation and lactation. Immediately after weaning, offspring hippocampi were isolated. Maternal high fructose consumption attenuated the mitochondrial O2 consumption rate and stimulated lipid hydroperoxide production in the hippocampi of offspring. Reduced Ucp5 and mitochondrial transcription factor A (Tfam) mRNA levels were also observed after maternal exposure to fructose. We assessed the promoter regions of both genes and found that this treatment enhanced DNA methylation levels. In addition, luciferase assays showed that this DNA methylation could reduce the transcription of both genes. Chromatin immunoprecipitation analysis demonstrated that specificity protein 1 binding to the Ucp5 promoter regions was reduced by DNA methylation. In addition, Ucp5 knockdown induced the up-regulation of reactive oxygen species levels in a rat brain glioma cell line, whereas reduced O2 consumption was observed with Tfam knockdown. Maternal high fructose intake thus induces reduced O2 oxygen consumption and increases oxidative stress in offspring, at least partly through epigenetic mechanisms involving Ucp5 and Tfam.-Yamada, H., Munetsuna, E., Yamazaki, M., Mizuno, G., Sadamoto, N., Ando, Y., Fujii, R., Shiogama, K., Ishikawa, H., Suzuki, K., Shimono, Y., Ohashi, K., Hashimoto, S. Maternal fructose-induced oxidative stress occurs viaTfam and Ucp5 epigenetic regulation in offspring hippocampi.
  • Eiji Munetsuna, Hiroya Yamada, Mirai Yamazaki, Yoshitaka Ando, Genki Mizuno, Yuji Hattori, Nao Sadamoto, Hiroaki Ishikawa, Yoshiji Ohta, Ryosuke Fujii, Koji Suzuki, Shuji Hashimoto, Koji Ohashi
    The Journal of nutritional biochemistry 67 44-50 2019年5月  査読有り
    Global fructose consumption is on the rise; however, maternal high-fructose intake may have adverse effects on offspring. We previously demonstrated that excessive fructose intake by rat dams altered steroidogenic gene transcription in the hippocampus of offspring. Herein, we examined how maternal high-fructose intake influences the regulation of adrenal glucocorticoid levels in offspring. Rat dams received 20% fructose solution during gestation and lactation. After weaning, the offspring were provided normal water. Maternal high-fructose intake did not alter mRNA expression levels of adrenal corticosterone-synthesizing and corticosterone-inactivating proteins or the circulating adrenocorticotropic hormone levels of offspring at postnatal day (PD) 21; however, it increased circulating corticosterone levels and decreased mRNA and protein levels of adrenal 5α-reductase type 1 and 11β-hydroxysteroid dehydrogenase type 2 in offspring at PD160. Furthermore, maternal high-fructose intake enhanced DNA methylation of the adrenal 5α-reductase 1 promoter region in PD160 offspring. Thus, maternal high-fructose intake was found to affect adrenal steroid hormone clearance in adult offspring - at least in part - through epigenetic mechanisms.
  • Mari Kondo, Hiroya Yamada, Eiji Munetsuna, Mirai Yamazaki, Takeshi Hatta, Akihiko Iwahara, Koji Ohashi, Hiroaki Ishikawa, Yoshiki Tsuboi, Takashi Inoue, Ryosuke Fujii, Koji Suzuki
    Archives of Gerontology and Geriatrics 82 155-160 2019年5月  査読有り
  • Fujii R, Yamada H, Munetsuna E, Yamazaki M, Ando Y, Mizuno G, Tsuboi Y, Ohashi K, Ishikawa H, Hagiwara C, Maeda K, Hashimoto S, Suzuki K
    Am J Clin Nutr 110(5) 1213-1219 2019年  査読有り
  • Fuji R, Yamada H, Munetsuna E, Yamazaki M, Mizuno G, Tsuboi Y, Ohashi K, Ishikawa H, Ando Y, Hagiwara C, Maeda K, Hashimoto S, Hamajima N, Suzuki K
    Nutrition 65 15 2019年  査読有り
  • Fuji R, Yamada H, Munetsuna E, Yamazaki M, Ohashi K, Ishikawa H, Maeda K, Hagiwara C, Ando Y, Hashimoto S, Hamajima N, Suzuki K
    J Epidemiol In press 2019年  査読有り
  • Hiroaki Ishikawa, Hiroya Yamada, Kanako Kondo, Takeru Ota, Mirai Yamazaki, Yoshitaka Ando, Genki Mizuno, Eiji Munetsuna, Koji Suzuki, Ryoji Teradaira, Koji Ohashi
    Annals of clinical biochemistry 56(1) 49-55 2019年1月  査読有り
    BACKGROUND: MicroRNAs are present not only in exosomes but also in high-density lipoprotein (HDL) and have the potential as biomarkers for various diseases. Various purification methods have been developed to quantify HDL-miRNAs; however, they are unsuitable for clinical applications. Therefore, we aimed to establish a simpler analytical method to quantify HDL-miRNAs for clinical applications. METHODS: We purified HDL fraction from pooled plasma using a three-step protocol consisting of ultracentrifugation, phosphotungstic acid/MgCl2 precipitation and desalting/buffer exchange followed by the quantification of HDL-miRNAs by quantitative real-time PCR. In order to establish a method to quantify HDL-miRNAs by quantitative real-time PCR, we prepared standard curves for miR-223 and miR-92. The HDL-miRNAs of 10 volunteers were assessed. RESULTS: Exosomes and LDL were not detected in the purified HDL fraction. Furthermore, we confirmed that only HDL was purified and that the HDL recovery rate of our method was at least approximately 50%. The threshold cycle values of miR-223, miR-92, miR-146a and miR-150 in the same subject were 32.11 ± 0.58, 32.50 ± 0.35, 34.30 ± 0.70 and 34.91 ± 0.77, respectively ( n = 10). The coefficient of variation values for these miRNAs were 1.08-2.21%. In addition, the standard curve for the quantitative analysis of miRNAs showed high linearity (30-30,000 copies/ μL) with a correlation coefficient of >0.99. The concentrations of HDL-miR-223 and HDL-miR-92 in the plasma of 10 subjects were 1.98 ± 0.32 and 0.90 ± 0.14 copies/mL (×104). CONCLUSIONS: We established a simple method for quantifying HDL-miRNAs and improved the sample processing capacity compared with conventional methods.
  • Eiji Munetsuna, Hiroya Yamada, Yoshitaka Ando, Mirai Yamazaki, Yoshiki Tsuboi, Mari Kondo, Genki Mizuno, Hiroaki Ishikawa, Keiko Sugimoto, Keisuke Osakabe, Naohiro Ichino, Koji Ohashi, Nobuyuki Hamajima, Koji Suzuki
    Annals of clinical biochemistry 55(4) 437-445 2018年7月  査読有り
    Purpose It has been demonstrated that circulating microRNA profiles are affected by physiological conditions. Several studies have demonstrated that microRNAs play important roles in the regulation of adiposity. However, few have investigated the relationship between circulating microRNAs and obesity, which has become a major public health problem worldwide. This study investigated the association between circulating microRNAs and obesity in a Japanese population. Methods Obesity parameters, such as subcutaneous and visceral fat adipose tissue, body fat percentage, and body mass index were assessed in a cross-sectional sample of 526 participants who attended health examinations in Yakumo, Japan. In addition, five circulating microRNAs (miR-20a, -21, -27a, -103a, and -320), which are involved in adipocyte proliferation and differentiation, were quantified using real-time polymerase chain reaction amplification. Results We compared the circulating microRNA concentrations in a percentile greater than 75th (high) with below the value (low) of subcutaneous adipose tissue, visceral fat adipose tissue, body mass index, and per cent body fat. For visceral fat adipose tissue, significant decrease in miR-320 expression was observed in high group. Also, for body mass index, significant change of miR-20a, -27a, 103a, and 320 expression level was observed in high group. Multiple linear regression analysis demonstrated that circulating levels of some microRNA such as miR-27a were significantly associated with subcutaneous adipose tissue, visceral fat adipose tissue, and body mass index. Conclusions Our findings support the need for further studies to determine whether such changes are consistent across different populations and whether the identified microRNAs may represent novel biomarkers to predict the susceptibility and progression of obesity-related disorders.
  • Munetsuna E, Yamada H, Yamazaki M, Ando Y, Mizuno G, Ota T, Hattori Y, Sadamoto N, Suzuki K, Ishikawa H, Hashimoto S, Ohashi K
    Life Sc 202 117-123 2018年  査読有り
  • Tsuboi Y, Yamada H, Munetsuna E, Yamazaki M, Mizuno G, Murase Y, Ohashi K, Ishikawa H, Kondo M, Inoue T, Hashimoto S, Hamajima N, Suzuki K
    J Atheroscler Thromb 25(12) 1231-1239 2018年  査読有り
  • Yamazaki M, Yamada H, Munetsuna E, Ishikawa H, Mizuno G, Mukuda T, Mouri A, Nabeshima T, Saito K, Suzuki K, Hashimoto S, Ohashi K
    FASEB J 32 2549-2562 2018年  査読有り
  • Genki Mizuno, Eiji Munetsuna, Hiroya Yamada, Yoshitaka Ando, Mirai Yamazaki, Yuri Murase, Kanako Kondo, Hiroaki Ishikawa, Ryoji Teradaira, Koji Suzuki, Koji Ohashi
    ENDOCRINE RESEARCH 42(1) 71-77 2017年  査読有り
  • Hiroaki Ishikawa, Hiroya Yamada, Nao Taromaru, Kanako Kondo, Ayuri Nagura, Mirai Yamazaki, Yoshitaka Ando, Eiji Munetsuna, Koji Suzuki, Koji Ohashi, Ryoji Teradaira
    ANNALS OF CLINICAL BIOCHEMISTRY 54(1) 134-142 2017年1月  査読有り
  • Mirai Yamazaki, Eiji Munetsuna, Hiroya Yamada, Yoshitaka Ando, Genki Mizuno, Yuri Murase, Kanako Kondo, Hiroaki Ishikawa, Ryoji Teradaira, Koji Suzuki, Koji Ohashi
    LIFE SCIENCES 149 146-152 2016年3月  査読有り
  • Ohashi K, Munetsuna E, Yamada H, Ando Y, Yamazaki M, Taromaru N, Nagura A, Ishikawa H, Suzuki K, Teradaira R, Hashimoto S
    Biochem Biophys Res Commun 468(1-2) 185-189 2015年12月  査読有り
  • Hiroya Yamada, Koji Ohashi, Koji Suzuki, Eiji Munetsuna, Yoshitaka Ando, Mirai Yamazaki, Hiroaki Ishikawa, Naohiro Ichino, Ryouji Teradaira, Shuji Hashimoto
    CLINICA CHIMICA ACTA 446 267-271 2015年6月  査読有り
  • Ohashi K, Ando Y, Munetsuna E, Yamada H, Yamazaki M, Nagura A, Taromaru N, Ishikawa H, Suzuki K, Teradaira R
    Nutr Res 35(3) 259-264 2015年3月  査読有り
  • Ishikawa H, Ohashi K, Ogitsu N, Nagamura Y
    Int J Anal Bio-Sci 3(2) 25-32 2015年  
  • Ishikawa H, Muramatsu C, Ohashi K, Ogitsu N, Nagamura Y
    Int J Anal Bio-Sci 1(2) 71-76 2013年  
  • 寺平 良治, 石川 浩章, 川井 薫, 堀口 敦史, 大橋 鉱二, 北川 文彦, 平光 伸也, 岩瀬 正嗣, 伊藤 康宏
    心療内科 10 433-437 2006年  
  • 寺平 良治, 杉本 邦彦, 川井 薫, 石川 浩章, 伊藤 康宏, 平光 伸也, 岩瀬 正嗣
    心療内科 10 137-141 2006年  
  • 石川 浩章, 前河 裕一, 大橋 鉱二, 荻津 直通, 大島 久二, 長村 洋一
    生物試料分析 28 452-457 2005年  
  • 石川 浩章, 大橋 鉱二, 荻津 直通, 大島 久二, 長村 洋一
    生物試料分析 28 445-451 2005年  
  • 石川 浩章, 松澤 健夫, 林 孝典, 大橋 鉱二, 荻津 直通, 大島 久二, 長村 洋一
    藤田学園医学会誌 28 1-4 2004年  
  • H Ishikawa, T Matsuzawa, K Ohashi, Y Nagamura
    ANNALS OF CLINICAL BIOCHEMISTRY 40 264-268 2003年5月  査読有り
  • 石川浩章藤田, 孝, 大橋 鉱二, 石井 潤一, 荻津 直通, 長村 洋一
    生物試料分析 24 283-288 2001年  
  • 石川浩章, 北川 章, 長村洋一
    医学と生物学 138(1) 5-7 1999年  

MISC

 12

書籍等出版物

 4

講演・口頭発表等

 64

担当経験のある科目(授業)

 2

共同研究・競争的資金等の研究課題

 1

教育方法・教育実践に関する発表、講演等

 1
  • 件名
    -
    終了年月日
    2009/08/01
    概要
    過去3年間の臨床検査技師国家試験対策について 第2回 医療科学部相互研修FD